Search Results - "Crocchiolo, R"

Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation by Crucitti, L, Crocchiolo, R, Toffalori, C, Mazzi, B, Greco, R, Signori, A, Sizzano, F, Chiesa, L, Zino, E, Lupo Stanghellini, M T, Assanelli, A, Carrabba, M G, Marktel, S, Marcatti, M, Bordignon, C, Corti, C, Bernardi, M, Peccatori, J, Bonini, C, Fleischhauer, K, Ciceri, F, Vago, L

“…Genomic loss of the mismatched human leukocyte antigen (HLA) is a recently described mechanism of leukemia immune escape and relapse after allogeneic…”
Get full text

Infections after T-replete haploidentical transplantation and high-dose cyclophosphamide as graft-versus-host disease prophylaxis by Crocchiolo, R., Bramanti, S., Vai, A., Sarina, B., Mineri, R., Casari, E., Tordato, F., Mauro, E., Timofeeva, I., Lugli, E., Mavilio, D., Carlo-Stella, C., Santoro, A., Castagna, L.

“…Background Recently, a platform of T‐cell replete haploidentical hematopoietic stem cell transplantation (haplo‐HSCT) using post‐transplant cyclophosphamide…”
Get full text

Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors by Peccatori, J, Forcina, A, Clerici, D, Crocchiolo, R, Vago, L, Stanghellini, M T L, Noviello, M, Messina, C, Crotta, A, Assanelli, A, Marktel, S, Olek, S, Mastaglio, S, Giglio, F, Crucitti, L, Lorusso, A, Guggiari, E, Lunghi, F, Carrabba, M, Tassara, M, Battaglia, M, Ferraro, A, Carbone, M R, Oliveira, G, Roncarolo, M G, Rossini, S, Bernardi, M, Corti, C, Marcatti, M, Patriarca, F, Zecca, M, Locatelli, F, Bordignon, C, Fleischhauer, K, Bondanza, A, Bonini, C, Ciceri, F

“…Hematopoietic stem cell transplantation (HSCT) from human leukocyte antigen (HLA) haploidentical family donors is a promising therapeutic option for high-risk…”
Get full text

Risk factors of Ganciclovir-related neutropenia after allogeneic stem cell transplantation: a retrospective monocentre study on 547 patients by Venton, G., Crocchiolo, R., Fürst, S., Granata, A., Oudin, C., Faucher, C., Coso, D., Bouabdallah, R., Berger, P., Vey, N., Ladaique, P., Chabannon, C., Merlin, M. le, Blaise, D., El-Cheikh, J.

“…Cytomegalovirus (CMV) infection is a serious complication that may occur in the weeks or months following bone marrow transplantation. However, both…”
Get full text

Nonmyeloablative conditioning, unmanipulated haploidentical SCT and post-infusion CY for advanced lymphomas by Castagna, L, Bramanti, S, Furst, S, Giordano, L, Crocchiolo, R, Sarina, B, Mauro, E, Morabito, L, Bouabdallah, R, Coso, D, Balzarotti, M, Broussais, F, El-Cheikh, J, Stella, C C, Brusamolino, E, Blaise, D, Santoro, A

“…Allo-SCT is regularly performed in advanced lymphoma. Haploidentical family donors are a valuable source of hematopoietic stem cells and transplants from these…”
Get full text

Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma by Castagna, L, Bramanti, S, Devillier, R, Sarina, B, Crocchiolo, R, Furst, S, El-Cheikh, J, Granata, A, Faucher, C, Harbi, S, Morabito, L, Mariotti, J, Puvinathan, S, Weiller, P J, Chabannon, C, Mokart, D, Carlo-Stella, C, Bouabdallah, R, Santoro, A, Blaise, D

“…We investigated the use of haploidentical hematopoietic stem cell transplantation (haplo-HSCT) in the treatment of advanced Hodgkin lymphoma (HL). Sixty-two…”
Get full text

The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCT by Devillier, R, Crocchiolo, R, Castagna, L, Fürst, S, El Cheikh, J, Faucher, C, Prebet, T, Etienne, A, Chabannon, C, Vey, N, Esterni, B, Blaise, D

“…We previously reported that reduced intensity conditioning (RIC) regimen with fludarabine, BU and 2.5 mg/kg of rabbit anti-thymocyte globulin (r-ATG) was…”
Get full text

B-cell reconstitution recapitulates B-cell lymphopoiesis following haploidentical BM transplantation and post-transplant CY by Roberto, A, Castagna, L, Gandolfi, S, Zanon, V, Bramanti, S, Sarina, B, Crocchiolo, R, Todisco, E, Carlo-Stella, C, Tentorio, P, Timofeeva, I, Santoro, A, Bella, S Della, Roederer, M, Mavilio, D, Lugli, E

Get full text

The patient’s CMV serological status affects clinical outcome after T-cell replete haplo-HSCT and post-transplant cyclophosphamide by Crocchiolo, R, Castagna, L, Furst, S, Devillier, R, Sarina, B, Bramanti, S, El-Cheikh, J, Granata, A, Harbi, S, Morabito, L, Faucher, C, Rimondo, A, Girardi, D, Mohty, B, Calmels, B, Carlo-Stella, C, Chabannon, C, Bouabdallah, R, Santoro, A, Vey, N, Weiller, P J, Blaise, D

Get full text

Impact of HLA-G polymorphism on the outcome of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma by Crocchiolo, R, Ringden, O, Bay, J-O, Blaise, D, Omasic, B, Mazzi, B, Picard, C, Trinca, S, Barkholt, L, Peccatori, J, Gregori, S, Amodio, G, Fleischhauer, K, Ciceri, F, Bregni, M

“…Renal cell carcinoma (RCC) is particularly sensitive to immune intervention. HLA-G, a non-classical HLA class I molecule with immunomodulatory properties, has…”
Get full text

T-replete haploidentical allogeneic transplantation using post-transplantation cyclophosphamide in advanced AML and myelodysplastic syndromes by Devillier, R, Bramanti, S, Fürst, S, Sarina, B, El-Cheikh, J, Crocchiolo, R, Granata, A, Chabannon, C, Morabito, L, Harbi, S, Faucher, C, Santoro, A, Weiller, P-J, Vey, N, Carlo-Stella, C, Castagna, L, Blaise, D

“…Unmanipulated haploidentical transplantation (Haplo-SCT) using post-transplantation cyclophosphamide (PT-Cy) represents an alternative for patients with…”
Get full text

Chronic GVHD is associated with inferior relapse risk irrespective of stem cell source among patients receiving transplantation from unrelated donors by Signori, A, Crocchiolo, R, Oneto, R, Sacchi, N, Sormani, M P, Fagioli, F, Rambaldi, A, Ciceri, F, Bacigalupo, A

“…Chronic GVHD (cGVHD) has been associated with reduced risk of relapse after allo-SCT for onco-hematological disease due to a graft-vs-malignancy effect. Here…”
Get full text

Skin allograft for severe chronic GvHD by Crocchiolo, R, Dubois, V, Nicolini, F-E, Sobh, M, Ducastelle-Lepretre, S, Labussiere, H, Lebras, L, Auxenfans, C, Mojallal, A, Damour, O, Braye, F, Michallet, M

Get full text

The calcineurin inhibitor and the intensity of the conditioning regimen may affect the occurrence of polyomavirus-associated hemorrhagic cystitis after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide by Rimondo, A, Crocchiolo, R, El-Cheikh, J, Bramanti, S, Granata, A, Furst, S, Sarina, B, Morabito, L, Devillier, R, Harbi, S, Mohty, B, Mineri, R, Faucher, C, Chabannon, C, Santoro, A, Blaise, D, Castagna, L

Get full text

Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma by Castagna, L, Bramanti, S, Devillier, R, Sarina, B, Crocchiolo, R, Furst, S, El-Cheikh, J, Granata, A, Faucher, C, Harbi, S, Morabito, L, Mariotti, J, Puvinathan, S, Weiller, P J, Chabannon, C, Mokart, D, Carlo-Stella, C, Bouabdallah, R, Santoro, A, Blaise, D

Get full text

Pre-transplantation risk factors to develop sclerotic chronic GvHD after allogeneic HSCT: A multicenter retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) by Detrait, M Y, Morisset, S, Peffault de Latour, R, Yakoub-Agha, I, Crocchiolo, R, Tabrizi, R, Bay, J-O, Chevalier, P, Barraco, F, Raus, N, Vigouroux, S, Magro, L, Mohty, M, Milpied, N, Blaise, D, Socié, G, Michallet, M

“…Sclerotic chronic GvHD (cGvHD) is one of the most severe complications after allo-hematopoietic stem cell transplantation (HSCT). Risk factors associated with…”
Get full text

Chronic GVHD is associated with lower relapse risk irrespective of stem cell source among patients receiving transplantation from unrelated donors by SIGNORI, A, CROCCHIOLO, R, ONETO, R, SACCHI, N, SORMANI, M. P, FAGIOLI, F, RAMBALDI, A, CICERI, F, BACIGALUPO, A

“…Chronic GVHD (cGVHD) has been associated with reduced risk of relapse after allo-SCT for onco-hematological disease due to a graft-vs-malignancy effect. Here…”
Get full text

Familial haploidentical challenging unrelated donor Allo-SCT in advanced non-Hodgkin lymphomas when matched related donor is not available by Garciaz, S, Castagna, L, Bouabdallah, R, Fürst, S, Bramanti, S, Coso, D, Crocchiolo, R, El-Cheikh, J, Broussais, F, Chabannon, C, Santoro, A, Blaise, D

Get full text

First-line extracorporeal photochemotherapy for acute GVHD after unmanipulated haploidentical BMT following nonmyeloablative conditioning and post transplantation CY by Castagna, L, Morabito, L, Mauro, E, Perotti, C, Bramanti, S, Sarina, B, Giordano, L, Crocchiolo, R, Santoro, A

Get full text

The conundrum of HLA-DRB114:01 14:54 and HLA-DRB302:01 02:02 mismatches in unrelated hematopoietic SCT by Pasi, A, Crocchiolo, R, Bontempelli, M, Carcassi, C, Carella, G, Crespiatico, L, Garbarino, L, Mascaretti, L, Mazzi, B, Mazzola, G, Miotti, V, Porfirio, B, Tagliaferri, C, Valentini, T, Vecchiato, C, Fleischhauer, K, Sacchi, N, Bosi, A, Martinetti, M

“…Uncertainty still exists on the role of polymorphisms outside the HLA-DRB1 binding site or inside the HLA-DRB3 binding groove in unrelated hematopoietic SCT…”
Get full text